Antacid Market Size Worth USD 7.91 Billion by 2025 | CAGR: 3.9%: Grand View Research, Inc.

Tuesday, January 22, 2019 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, January 22, 2019 /PRNewswire/ --

The global antacid market size is expected to reach USD 7.91 billion by 2025

, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast period. The trend of self-medication for occasional heartburn is one of the major factors driving the market.


(Logo: )

Key suggestions from the report:  

  • In 2017, tablet segment led the antacid market due to high efficacy compared to other dosage forms. Liquid is anticipated to be the fastest growing segment due to its palatable taste and preferred choice for children and elderly population 
  • Retail pharmacy led the distribution channel segment due its accessibility and availability. Online pharmacy is anticipated to be the fastest growing segment due to growing adoption of Pharma 3.0 and consumer awareness 
  • Asia Pacific is estimated to be the largest and fastest growing region over the forecast period due to presence of key players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others 
  • North America held the second largest market share in 2017 owing to increasing prevalence of different digestive disorders 
  • Some of the key companies operating in this market are GlaxoSmithKline plc; Bayer AG; Boehringer Ingelheim International GmbH; Dr. Reddy's Laboratories Ltd.; Reckitt Benckiser Group plc; Sun Pharmaceuticals Ltd.; Sanofi; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble. 

Read 90 page research report with TOC on "Antacids Market Size, Share & Trends Analysis Report By Dosage Form (Tablet, Liquid), By Distribution Channel (Retail, Hospital, Online Pharmacy), By Region (APAC, Europe, North America), And Segment Forecasts, 2019 - 2025" at:

Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%.

Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio.

Connect with our analyst for specific inquiries about this market

The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players are GlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.

Grand View Research has segmented the global antacid market based on dosage form, distribution channel, and region: 

  • Antacid Dosage Form Outlook (Revenue, USD Million, 2014 - 2025) 
    • Tablet
    • Liquid
    • Others
  • Antacid Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025) 
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Antacid Regional Outlook (Revenue, USD Million, 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

Browse related reports by Grand View Research: 

  • Food Allergy Market -  The Global food allergy market is anticipated to witness noteworthy growth over the forecast period owing to an alarming rise in the number of food allergies
  • Veterinary Pain Management Market - The global veterinary pain management market is expected to witness significant growth over the forecast period. 
  • Sickle Cell Disease Treatment Market - The global sickle cell disease treatment market size was valued at USD 2.1 billion in 2017 and is anticipated to exhibit a CAGR of 14.3% during the forecast period.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email:


Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store